Related Experiment Video
Updated: Jan 10, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[Chagas disease in a low-income setting in the surrounding area of Buenos Aires]
Ainoha Vilariño1, Byron Castañeda1, Eduardo Warley1
1Unidad de Infectología, Hospital Interzonal General de Agudos Dr. Diego Paroissien, La Matanza, Buenos Aires, Argentina.
Introduction:
La Matanza district, located in the western zone of Buenos Aires Metropolitan Area, has a population of 1837774, with a high proportion of migrants from regions endemic for Chagas disease (CD). Our hospital serves as the local referral center and reactivated a dedicated CD outpatient clinic in October 2023. The objectives of this study were to describe the collected data, characterize the patient population, identify the available epidemiological information, and assess the initial response to follow-up and adherence to trypanocidal therapy.
Material And Methods:
We conducted an observational, descriptive, and retrospective study of 61 patients evaluated between October 2023 and May 2024.
Results:
The study revealed a relatively high mean age and a high prevalence of Chagas-related cardiomyopathy, resulting in a majority of patients being ineligible for treatment compared to those who qualified. Attempts to obtain official epidemiological data on CD in the district were unsuccessful, highlighting a substantial degree of underreporting. Approximately 35% (21) of patients were lost to follow-up, although all prescribed treatments were completed successfully.
Discussion:
This study underscores the delayed suspicion and diagnosis of CD, as well as the absence of epidemiological data in a densely populated and highly migratory area. These findings reinforce the need to establish integrated services for comprehensive management of CD, decentralize care delivery, and promote the foundational principles of Chagas care: consider CD, diagnose CD, and treat CD.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

